Crossmark

Diferencias entre agalsidasa α y agalsidasa β en el tratamiento de la enfermedad de Fabry

Crossref DOI link: https://doi.org/10.1016/j.medcli.2017.03.054

Published Print: 2017-09

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Pérez-López, Jordi

Domínguez Gil-Hurlé, Alfonso

López Rodríguez, Mónica
License Information

Text and Data Mining valid from 2017-09-01
More Information

This article is maintained by: Elsevier

Article Title: Diferencias entre agalsidasa α y agalsidasa β en el tratamiento de la enfermedad de Fabry

Journal Title: Medicina Clínica

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.medcli.2017.03.054

Content Type: simple-article

Copyright: © 2017 Elsevier España, S.L.U. All rights reserved.